Skip to main content

Healthcare & Biotech

Onix Raises $5M Pre-Seed Led by Alpha Edison for Expert-Owned AI

Image
Onix Raises $5M Pre-Seed Led by Alpha Edison for Expert-Owned AI

Montreal – September 13, 2026 -- Onix, the Montreal-based startup behind what it calls Personal Intelligence, has closed $5 million USD (roughly $7 million CAD) in pre-seed funding led by Los Angeles-based Alpha Edison, with participation from Garage Capital, Ride Home Fund, and strategic backers Jeremy Zimmer, co-founder of UTA, and JS Cournoyer, co-founder of Real Ventures.

Round size dwarfs typical Canadian pre-seed deals

According to the Canadian Venture Capital and Private Equity Association, the raise is more than seven times the average Canadian pre-seed deal recorded in 2025 and exceeds the average Canadian seed round. U.S. investor participation in Canadian pre-seed deals fell from 23% in 2024 to 8% in 2025, making Alpha Edison's lead investment in a Canadian company a departure from that broader retreat.

MacroHealth Names Erica Tingley as Chief Financial Officer

Image
MacroHealth Names Erica Tingley as Chief Financial Officer

Kirkland – September 13, 2026 -- MacroHealth, a marketplace platform connecting healthcare payers and plan administrators with vendor partners, has appointed Erica Tingley as Chief Financial Officer to oversee financial and operational scaling as the company expands its service categories.

Tingley brings 25 years of healthcare finance experience to the CFO role

Tingley's background spans investment banking, mergers and acquisitions, corporate finance and operations. She most recently served as President and CFO of Knowtion Health, a revenue cycle management partner to health systems, where she managed both financial strategy and solution delivery. Before that role, she was COO and CFO of Bluesight, where she worked on driving consistent, profitable growth. Earlier in her career, she held positions at The Advisory Board Company and Bank of America Merrill Lynch.

German Doctors' Union Warns Emergency Care Reform Risks Insurer Control

Image
German Doctors' Union Warns Emergency Care Reform Risks Insurer Control

Berlin – September 13, 2026 -- Germany's largest doctors' association, the Marburger Bund, has warned lawmakers that a draft reform of emergency medical care could hand health insurers de facto control over which local emergency sites survive, ahead of a public hearing before the Bundestag's Health Committee.

Marburger Bund backs the goal of linking outpatient and inpatient emergency care but flags flaws in the bill

Dr. Susanne Johna, chairwoman of the Marburger Bund, told the committee that better integration of ambulatory and hospital-based emergency structures is needed so patients reach the appropriate care point reliably. She cautioned, however, that the current draft contains provisions that could create new operational problems in practice.

Roundstone Sets 2027 Medical Captive Forum for Nashville, May 11-12

Image
Roundstone Sets 2027 Medical Captive Forum for Nashville, May 11-12

Rocky River, Ohio – September 13, 2026 -- Roundstone Insurance will hold its annual Medical Captive Forum (MCF) on May 11 and 12, 2027, in Nashville, Tennessee, bringing together hundreds of employer executives to tackle rising health plan costs.

Event targets employers moving away from fully insured health models

The complimentary two-day forum will gather CEOs, CFOs, HR leaders, benefits advisors, and healthcare innovators to discuss redesigning health plans for greater transparency, cost control, and long-term sustainability. Sessions will cover plan design, captive insurance structures, and cost containment strategies through panels, roundtables, and networking.

Roundstone reimburses attendees for lodging costs

Beyond complimentary programming, Roundstone will reimburse employers for one night's hotel stay, lowering the barrier for mid-market companies to attend.

MIB Agents Opens 2027 Osteosarcoma Grant Applications, Offers $150,000

Barnard, Vt. – September 13, 2026 -- MIB Agents began accepting letters of intent on September 9 for its 2027 OutSmarting Osteosarcoma research grant cycle, offering a combined $150,000 to fund translational studies on the pediatric bone cancer.

Two grants totaling $150,000 target established and emerging researchers

The 2027 cycle includes a $100,000 Hero Grant and a $50,000 Hope Young Investigator Grant. Since launching in 2017, the program has distributed more than $2.9 million across 37 investigators studying osteosarcoma, an aggressive primary bone cancer diagnosed in roughly 1,000 people annually in the United States, nearly half of them children, adolescents and young adults.

Findhelp Becomes First Registered Specialty Exchange Under Maryland MHCC

Image
Findhelp Becomes First Registered Specialty Exchange Under Maryland MHCC

Austin, Texas – September 13, 2026 -- Findhelp has become the first specialty exchange to register with the Maryland Health Care Commission (MHCC), enabling social care referral and reporting support for the state's Rural Health Transformation Program (RHTP).

Findhelp registers as Maryland's first specialty exchange under MHCC oversight

The registration allows Findhelp to help RHTP grant awardees manage social risk screening, referrals, data exchange, and reporting requirements. Health care providers and community-based organizations (CBOs) gain specialized technical capabilities intended to reduce barriers in care coordination for rural patients.

Albaron Partners Sells Prime Psychiatry to Beacon Behavioral Partners

New York – September 13, 2026 -- Albaron Partners, LP has completed the sale of Texas-based Prime Wellness LLC, doing business as Prime Psychiatry, to Beacon Behavioral Partners, ending a four-year buildout of the outpatient and interventional psychiatry provider.

Albaron built Prime Psychiatry into a regional platform since 2022

Albaron partnered with founder Dr. Efosa Airuehia in 2022 to scale Prime Psychiatry across the Dallas-Fort Worth and Austin metro areas. The practice treats children, adolescents, and adults, offering anxiety and depression treatment, medication management, TMS, and Spravato therapy.

Clearway Health Names Rishi Seth Chief Operating Officer

Image
Clearway Health Names Rishi Seth Chief Operating Officer

Boston – September 13, 2026 -- Clearway Health has appointed Rishi Seth as chief operating officer, adding a 20-year healthcare operations veteran to its executive leadership team as the specialty pharmacy sector undergoes rapid change.

Seth brings two decades of healthcare integration experience to Clearway Health

Seth most recently served as senior vice president of integration at Millennium Physician Group, one of the largest independent physician groups in the United States, where he led integration of new provider groups and strategic partnerships. He previously held senior leadership positions at Optum Health and Privia Health, focusing on multidisciplinary scalability across clinical operations, finance, technology, human resources and revenue cycle functions.

German Science Bodies Demand Cross-Ministry Health Prevention Strategy

Berlin – September 13, 2026 -- Four of Germany's leading scientific and health organizations have issued a joint call for a cross-departmental national prevention strategy, warning that roughly 40 percent of new cancer cases remain preventable despite decades of research.

Four organizations unite behind a joint policy statement

The Leopoldina National Academy of Sciences, the German Council of Science and Humanities (Wissenschaftsrat), the German Cancer Research Center (DKFZ) and German Cancer Aid (Deutsche Krebshilfe) presented a shared statement demanding that prevention be embedded across all policy fields -- including education, labor, transport, urban planning, environment and social affairs -- rather than confined to the health ministry alone.

LUMA Vision Wins FDA Clearance for VERAFEYE Ahead of 2027 Launch

Image
LUMA Vision Wins FDA Clearance for VERAFEYE Ahead of 2027 Launch

Dublin – – September 13, 2026 -- LUMA Vision has secured an expanded FDA clearance for VERAFEYE, its procedural intelligence platform for minimally invasive cardiac procedures, moving the company closer to a planned commercial launch in early 2027.

VERAFEYE now unifies digital anatomy creation, catheter tracking, and guidance on a single platform

The new clearance allows VERAFEYE to reconstruct 3D models of the left and right atria with CT-like accuracy using a single 360° imaging catheter that captures raw ultrasound data. The platform lets physicians visualize and document ablation delivery directly on the anatomy while maintaining continuous tracking of both imaging and ablation catheters through electromagnetic tracking and automated imaging.